Reduction in IκB kinase α expression promotes the development of skin papillomas and carcinomas

Cancer Research

Volumn 67, Issue 19, 2007, Pages 9158-9168

  Park, Eunmi ^a   Zhu, Feng ^a   Liu, Bigang ^a   Xia, Ojun ^a   Shen, Jianjun ^a   Bustos, Tracie ^a   Fischer, Susan M ^a   Hu, Yinling ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; AMPHIREGULIN; DIMETHYLBENZ[A]ANTHRACENE; DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 13; FIBROBLAST GROWTH FACTOR 2; H RAS PROTEIN; I KAPPA B KINASE ALPHA; INTERLEUKIN 1ALPHA; PHORBOL 13 ACETATE 12 MYRISTATE; RAS PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN A; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN; I KAPPA B KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME BINDING; GENE MUTATION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; HEMIZYGOSITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOMA; SKIN PAPILLOMA; AMINO ACID SEQUENCE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CARCINOMA; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; ENZYMOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOLECULAR GENETICS; MUTATION; NEOVASCULARIZATION (PATHOLOGY); ONCOGENE RAS; PAPILLOMA; PATHOLOGY; SKIN TUMOR; VASCULARIZATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CARCINOGENS; CARCINOMA; COCARCINOGENESIS; FEMALE; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; I-KAPPA B KINASE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PAPILLOMA; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 35148897233     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0590     Document Type: Article

References (36)

1. Liu B, Park E, Zhu F, et al. A critical role for IκB kinase α in the development of human and mouse squamous cell carcinomas. Proc Natl Acad Sci U S A 2006;103:17202-7.
2. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 2000;18:621-63.
3. Senftleben U, Cao Y, Xiao G, et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science 2001;293:1495-9.
4. -/- mice that express an IKKα transgene in keratin 5+ thymic epithelial cells. J Immunol 2007;178:829-37.
5. Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase. Science 1999;284:316-20.
6. Li Q, Lu Q, Hwang JY, et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 1999;13:1322-8.
7. Takeda K, Takeuchi O, Tsujimura T, et al. Limb and skin abnormalities in mice lacking IKKα. Science 1999; 284:313-6.
8. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKα controls formation of the epidermis independently of NF-κB. Nature 2001;410:710-4.
9. Sil AK, Maeda S, Sano Y, Roop DR, Karin M. IKKα acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature 2004;428:660-4.
10. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN. Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 1991;4:196-202.
11. Spencer JM, Kahn SM, Jiang W, DeLeo VA, Weinstein IB. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995;131:796-800.
12. Kiguchi K, Beltran L, Dubowski A, DiGiovanni J. Analysis of the ability of 12-O-tetradecanoylphorbol-13-acetate to induce epidermal hyperplasia, transforming growth factor-α, and skin tumor promotion in wa-1 mice. J Invest Dermatol 1997;108:784-91.
13. Yuspa SH. Molecular and cellular basis for tumor promotion in mouse skin. Princess Takamatsu Symp 1983;14:315-26.
14. Kemp CJ, Donehower LA, Bradley A, Balmain A. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell 1993;74:813-22.
15. Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin. Carcinogenesis 1993;14:2353-8.
16. Ise K, Nakamura K, Nakao K, et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene 2000;19:2951-6.
17. Mao JH, To MD, Perez-Losada J, Wu D, Del Rosario R, Balmain A. Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev 2004;18:1800-5.
18. Saleem M, Afaq F, Adhami VM, Mukhtar H. Lupeol modulates NF-κB and PI3K/Akt pathways and inhibits skin cancer in CD-1 mice. Oncogene 2004;23:5203-14.
19. Li Q, Lu Q, Bottero V, et al. Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1). Proc Natl Acad Sci U S A 2005;102:12425-30.
20. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 1997;91:243-52.
21. Correa RG, Matsui T, Tergaonkar V, et al. Zebrafish IκB kinase 1 negatively regulates NF-κB activity. Curr Biol 2005;15:1291-5.
22. Conti CJ. Vascular endothelial growth factor: regulation in the mouse skin carcinogenesis model and use in antiangiogenesis cancer therapy. The Oncologist 2002;7 Suppl 3:4-11.
23. Enholm B, Paavonen K, Ristimaki A, et al. Comparison of VEGF, VEGF-B, VEGF-C, and Ang-1 mRNA regulation by serum, growth factors, oncoproteins, and hypoxia. Oncogene 1997;14:2475-83.
24. Wang X J, Greenhalgh DA, Roop DR. Transgenic coexpression of v-Ha-ras and transforming growth factor α increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation. Mol Carcinog 2000;27:200-9.
25. Larcher F, Robles AI, Duran H, et al. Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res 1996;56:5391-6.
26. Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005;5:749-59.
27. Hu MC, Lee DF, Xia W, et al. IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 2004;117:225-37.
28. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-96.
29. Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL. Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis. Oncogene 1999;18:7423-31.
30. Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007;446:153-8.
31. Wei H, Frenkel K. In vivo formation of oxidized DNA bases in tumor promoter-treated mouse skin. Cancer Res 1991;51:4443-9.
32. Koster MI, Dai D, Marinari B, et al. p63 induces key target genes required for epidermal morphogenesis. Proc Natl Acad Sci U S A 2007;104:3255-60.
33. Candi E, Terrinoni A, Rufini A, et al. p63 is upstream of IKKα in epidermal development. J Cell Sci 2006;119:4617-22.
34. Koster MI, Lu SL, White LD, Wang XJ, Roop DR. Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. Cancer Res 2006;66:3981-6.
35. Hill R, Song Y, Cardiff RD, Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005;123:1001-11.
36. Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005;434:864-70.